Cargando…

New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency

Botulinum neurotoxins (BoNTs) are notorious toxins and powerful agents and can be lethal, causing botulism, but they are also widely used as therapeutics, particularly to treat neuromuscular disorders. As of today, the commercial BoNT treatments available are from native A or B serotypes. Serotype F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burgin, David, Périer, Cindy, Hackett, Gavin, Elliott, Mark, Kwan, Daniel, Hornby, Fraser, Mir, Imran, Maignel, Jacquie, Liu, Sai Man, Beard, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705745/ https://www.ncbi.nlm.nih.gov/pubmed/34941672 http://dx.doi.org/10.3390/toxins13120834

Ejemplares similares

Augmentation of VAMP-catalytic activity of botulinum neurotoxin serotype B does not result in increased potency in physiological systems
por: Elliott, Mark, et al.
Publicado: (2017)

Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H
por: Hackett, Gavin, et al.
Publicado: (2018)

Botulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies
por: Maignel‐Ludop, Jacquie, et al.
Publicado: (2017)

Engineered botulinum neurotoxin B with improved binding to human receptors has enhanced efficacy in preclinical models
por: Elliott, Mark, et al.
Publicado: (2019)

The Expanding Therapeutic Utility of Botulinum Neurotoxins
por: Fonfria, Elena, et al.
Publicado: (2018)

Recombinant botulinum neurotoxin serotype A1 in vivo characterization
por: Périer, Cindy, et al.
Publicado: (2021)

The Isolated Mouse Jejunal Afferent Nerve Assay as a Tool to Assess the Effect of Botulinum Neurotoxins in Visceral Nociception
por: Retailleau, Kevin, et al.
Publicado: (2022)

A comparison of biological activity of commercially available purified native botulinum neurotoxin serotypes A1 to F1 in vitro, ex vivo, and in vivo
por: Donald, Sarah, et al.
Publicado: (2018)

BoNT/A in the Urinary Bladder—More to the Story than Silencing of Cholinergic Nerves
por: Ibrahim, Hodan, et al.
Publicado: (2022)

Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice
por: Oehler, Beatrice, et al.
Publicado: (2022)

High resolution crystal structures of the receptor-binding domain of Clostridium botulinum neurotoxin serotypes A and FA
por: Davies, Jonathan R., et al.
Publicado: (2018)

Optimization of the rat digit abduction score (DAS) assay: Evaluation of botulinum neurotoxin activity in the gastrocnemius lateralis, peronei, and extensor digitorum longus
por: Cornet, Sylvie, et al.
Publicado: (2020)

Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies Using a Red Blood Cell-Targeting Fusion Protein
por: Adekar, Sharad P., et al.
Publicado: (2011)

Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics
por: Davies, Jonathan R., et al.
Publicado: (2018)

Engineered botulinum neurotoxin B with improved efficacy for targeting human receptors
por: Tao, Liang, et al.
Publicado: (2017)

The use of the dynamic weight bearing test to assess the effects of acute, intramuscularly administered botulinum neurotoxin type A1 in rats
por: Cornet, Sylvie, et al.
Publicado: (2020)

On Botulinum Neurotoxin Variability
por: Montecucco, Cesare, et al.
Publicado: (2015)

Botulinum Neurotoxin Serotype a Specific Cell-Based Potency Assay to Replace the Mouse Bioassay
por: Fernández-Salas, Ester, et al.
Publicado: (2012)

Content/Potency Assessment of Botulinum Neurotoxin Type-A by Validated Liquid Chromatography Methods and Bioassays
por: Xavier, Bruna, et al.
Publicado: (2019)

Why Are Botulinum Neurotoxin-Producing Bacteria So Diverse and Botulinum Neurotoxins So Toxic?
por: Poulain, Bernard, et al.
Publicado: (2019)

Production and characterization of cell-penetrating recombinant botulinum neurotoxin type A
por: Wei, Xuan, et al.
Publicado: (2023)

Engineering an Effective Human SNAP-23 Cleaving Botulinum Neurotoxin A Variant
por: Sikorra, Stefan, et al.
Publicado: (2020)

Zebrafish Sensitivity to Botulinum Neurotoxins
por: Chatla, Kamalakar, et al.
Publicado: (2016)

Use of Botulinum Neurotoxin in Ophthalmology
por: Başar, Emel, et al.
Publicado: (2016)

Antipruritic Effects of Botulinum Neurotoxins
por: Gazerani, Parisa
Publicado: (2018)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum neurotoxins: Future innovations
por: Brideau-Andersen, Amy, et al.
Publicado: (2023)

Conjugative Botulinum Neurotoxin-Encoding Plasmids in Clostridium botulinum
por: Marshall, Kristin M., et al.
Publicado: (2010)

Structural Features of Clostridium botulinum Neurotoxin Subtype A2 Cell Binding Domain
por: Gregory, Kyle S., et al.
Publicado: (2022)

Emerging Opportunities for Serotypes of Botulinum Neurotoxins
por: Peng Chen, Zhongxing, et al.
Publicado: (2012)

Engineering of Botulinum Neurotoxins for Biomedical Applications
por: Webb, Robert P.
Publicado: (2018)

Botulinum neurotoxin formulations: overcoming the confusion
por: Samizadeh, Souphiyeh, et al.
Publicado: (2018)

Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
por: Pirazzini, Marco, et al.
Publicado: (2017)

Botulinum Neurotoxin for the Treatment of Neuropathic Pain
por: Egeo, Gabriella, et al.
Publicado: (2020)

Tables of Toxicity of Botulinum and Tetanus Neurotoxins
por: Rossetto, Ornella, et al.
Publicado: (2019)

Botulinum Neurotoxin Injections in Childhood Opisthotonus
por: Hull, Mariam, et al.
Publicado: (2021)

Recent Developments in Botulinum Neurotoxins Detection
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2022)

Botulinum Neurotoxins: From Toxin to Medicine
por: Santamato, Andrea
Publicado: (2023)

A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency
por: Stern, Daniel, et al.
Publicado: (2018)

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
por: Derkaev, Artem A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gmr7a81ncggpqdjiueju9nh06u